Health
FDA Greenlights New Treatment for Rare Blood Cancer
By Editor • August 30, 2026 • 1 min read
The FDA has approved rusfertide, a new treatment for polycythemia vera, a rare blood cancer that causes excessive red blood cell production.
Read more